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Previous clinical vitamin A trials have found no consistent effect on diarrhoeal disease and respiratory tract infection. These inconsistent results
may be due to the distinct effects vitamin A supplementation has among children stratified by factors related to socio-economic status, nutritional
status and season. We evaluated the effect of supplementation on the overall incidence of diarrhoeal disease and respiratory tract infections and on
the incidence among children stratified by these factors. A total of 188 children, aged 6–15 months, from periurban, marginalized communities of
Mexico City were assigned to receive vitamin A (,12 months of age, 20 000 IU retinol; $12 months, 45 000 IU retinol) or a placebo every 2
months, and were followed for up to 15 months. Project personnel visited households twice a week to determine the onset and duration of diar-
rhoeal disease and respiratory tract infections. Vitamin A supplementation had no significant effect on risk of overall diarrhoeal disease but
reduced mild watery diarrhoea (incidence rate ratio (RR) 0·69; 95% CI 0·50, 0·93) and cough with fever (RR 0·69; 95% CI 0·48, 0·98). Vitamin
A supplementation decreased diarrhoeal disease during the summer (RR 0·74; 95% CI 0·57, 0·94), among non-stunted children (RR 0·69; 95% CI
0·52, 0·93) and among children from households with better socio-economic measures. Heterogeneity in the response to vitamin A supplementation
may reflect heterogeneity in the aetiology and epidemiology of diarrhoeal disease and respiratory tract infections and the impact that supplemen-
tation has on the immune response.
Vitamin A: Diarrhoea: Respiratory tract infections: Children: Mexico
Vitamin A supplementation has proven to be one of the most
cost-effective interventions for reducing mortality and severity
of infectious disease episodes among young children in devel-
oping countries (Hussey & Klein, 1990; Beaton et al. 1992;
Fawzi et al. 1993). Paradoxically, randomized, placebo-con-
trolled trials carried out in different parts of the world have
not found a consistent effect on the incidence of diarrhoeal
disease or respiratory tract infections (Ghana VAST Study
Team, 1993; Stansfield et al. 1993; Barreto et al. 1994;
Ramakrishnan et al. 1995; Dibley et al. 1996; Grotto et al.
2003). This inconsistency is difficult to explain, since a
reduction in disease incidence would be an obvious mechan-
ism responsible for child mortality reductions. One possible
explanation may be that vitamin A supplementation is redu-
cing case fatalities. However, a number of recently published
studies have reported that vitamin A reduces morbidity among
malnourished children while simultaneously increasing mor-
bidity among well-nourished children (Dibley et al. 1996;
Sempertegui et al. 1999; Fawzi et al. 2000). These earlier
results suggest that differences in childhood characteristics
may be modifying the effect vitamin A supplementation has
on morbidity. Any heterogeneity in effect introduced by
such characteristics may be attenuated when the analysis is
carried out at a more aggregate population level, and
this could explain the failure to find an overall impact of
vitamin A.
There may be extensive heterogeneity in diarrhoeal disease
incidence within and between communities in developing
countries due to differences in household access to potable
water and sanitation facilities (Esrey, 1996). In Latin America
the construction of water and sanitary facilities and the
implementation of diarrhoeal disease prevention programmes
have led to important reductions in diarrhoeal disease
(Velazquez et al. 2004). These reductions have not occurred
uniformly throughout the region due to the incomplete
implementation of such systems and programmes. Older,
more established communities found around the periphery of
large metropolitan centres have access to water and sanitary
facilities, but more recently founded communities have little
or no access. These differences can determine the children’s
degree of exposure to specific enteric and respiratory patho-
gens, and so may modify the effect supplementation has on
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specific childhood health outcomes. Further studies are needed
to address how the impact of vitamin A may differ between
children stratified by household and environmental character-
istics related to hygiene and pathogen exposure. This under-
standing may clarify what is responsible for inconsistencies
found in previous studies which have largely focused on
the aggregate effect of vitamin A. It could then allow the
development of more cost-effective vitamin A supplemen-
tation strategies in regions where epidemiological transitions
are occurring.
We have carried out a community-based, randomized,
double-blind, placebo-controlled trial of the impact of vitamin
A supplementation on diarrhoeal disease and respiratory tract
infections among children from Mexico City, Mexico. In this
paper we address the hypothesis that vitamin A supplemen-
tation reduces rates of diarrhoeal disease and respiratory
tract infections and that household and environmental factors
and season act as effect modifiers on this association.
Subjects and methods
Study area subjects and recruitment
The present study was carried out in peri-urban communities
that are part of the municipality of La Magdalena Atlicpac
located along the eastern perimeter of Mexico City. These
communities are made up of households that have migrated
at different times into the Valley of Mexico and, as a result,
differ in their degree of access to piped water, sanitary facili-
ties and overall development. Community health workers first
carried out a census of all children less than 2 years of age
living within these communities. Mothers of all eligible chil-
dren between the ages of 6 and 15 months were invited to par-
ticipate in the trial during household visits by project
personnel. Restricting the study to children of this age range
would allow us to evaluate the efficacy of supplementation
during the period when the children’s immune response is
developing. Children were excluded from the study if they
had diseases causing immunosuppression, or any congenital
or acquired alteration of the digestive tract that could alter
the absorption of micronutrients. Children who were taking
vitamin supplements were also excluded from the study. Over-
all, 200 children were enrolled in the study after their parents
had given informed consent for their participation.
Study design
The children, once enrolled, were randomly assigned to
receive vitamin A or a placebo balanced in blocks of
twenty. Children less than 12 months of age assigned to the
vitamin A group were administered a solution containing
20 000 IU of retinol [3·3 IU ¼ 1 retinol activity equivalent
(mg)] at baseline and subsequently every 2 months until the
end of the study while children older than 12 months received
a solution containing 45 000 IU of retinol. This dosage would
allow the evaluation of the impact of frequent low doses of
vitamin A on rates of diarrhoeal disease and respiratory tract
infections.
The randomization sequence was generated by project per-
sonnel based at the National Institute of Public Health. Person-
nel at the National Institute of Nutrition carried out the
preparation of the supplements to assure that field personnel
and the principal investigator were unaware of treatment regi-
men. Children in the vitamin A and placebo groups received a
5ml solution, from identical opaque plastic droplet bottles
numbered consecutively, administered by the field team. Test-
ing had been carried out at the National Institute of Nutrition
to assure that the placebo and vitamin A water miscible sol-
ution were similar in taste, viscosity and colour.
At the first household visit, mothers were interviewed to
determine the child’s morbidity experience in the previous 2
weeks. Information was also collected regarding the number
of household members, their ages, education levels and
income, household construction materials, the source and
quality of household water, the type of household sanitation
facilities and number of possessions that are electrical dom-
estic appliances. Finally, during this initial visit the mother
or child caretaker was asked to describe the feeding and wean-
ing patterns of the child. A previously validated questionnaire
was used in the collection of these data by project personnel
who had received training in its application.
Children were then followed prospectively for up to 15
months, with field personnel visiting households twice a
week. Mothers were interviewed during these visits to deter-
mine if the child had had the following symptoms: diarrhoea,
the presence of blood and mucus in stools, cough, difficulty
breathing and fever, and they were asked to report on the
number and consistency of evacuations by the child. Project
supervisors accompanied approximately 5% of all household
visits to assure quality of data collection. Children were
referred to the study physician for diagnosis and treatment
when the fieldworker or caregiver was concerned about the
child’s health status.
Trained personnel obtained weight and height measure-
ments from each child at the first household visit and once a
month thereafter to evaluate the nutritional status of each
child using calibrated methods and standardized techniques.
Children were weighed using a calibrated Salter scale (Salter
Weigh-Tronix Ltd, Monterrey, Mexico) while wearing light
clothing and their supine length was measured using a locally
constructed rigid measuring board. Training exercises at the
beginning of the study and at repeated intervals thereafter
were used to standardize these personnel.
The mother’s reporting of symptoms in the child was used
to define diarrhoeal disease episodes. A period of three or
more, symptom-free days was used in this analysis to define
the end of an episode. Acute diarrhoea was defined as an epi-
sode that lasted between 1 and 14 d while persistent diarrhoea
was defined as lasting more than 14 d. Acute diarrhoea was
classified as dysentery if blood or pus was present in the
stool or watery diarrhoea if no blood or pus was present. All
episodes of watery diarrhoea or dysentery were classified as
mild or moderate if the child passed ,5 movements on the
worst day or passed $5 movements but the episode lasted
#3 d; an episode was considered severe if the child had $5
movements on the worst day and the episode lasted .3 d
(Fawzi et al. 2000). These subgroups of diarrhoea were
mutually exclusive. Respiratory tract infection outcomes
were classified as cough alone, cough and fever, or cough
and rapid respiratory rate as reported by the mother. A new
episode was defined if there was an interval of 14 d or more
free of symptoms.
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Sample size and power
Sample sizes were calculated based on the assumption that the
study population has a diarrhoeal disease rate of three episodes
per child per year and that the vitamin A supplement would
reduce this rate by approximately 20%. This effect approxi-
mated the reduction in diarrhoea incidence reported by Barreto
et al. (1994) in their vitamin A trial in Brazil. It was calculated
that a sample size of 100 per group was required to detect a
20% reduction between the control and treatment group
with a power of 80% and 95% significance level and an
expected loss to follow-up of 20%. This calculation
allowed for repeated measurements of the outcome and a cor-
relation between measurements at different time-points of 0·7
(Frison & Pocock, 1992).
Statistical analysis
Data were entered in Visual Fox Pro 6·0 (Microsoft), verified,
and checked for range and consistency. Anthropometric indi-
cators were calculated by using sex- and age-specific stan-
dards developed by the US Centers for Disease Control and
Prevention (Ogden et al. 2002). Children with height-for-age
Z-scores below 22 were considered stunted, those with
weight-for-age Z-scores below 22 were classified as under-
weight children. Children with Z-scores at or above 22 in
both measurements were classified as non-stunted or normal
weight-for-age.
The end-points for the study were the incidence of diar-
rhoeal episodes and respiratory tract infections during the
follow-up of each child. The rate ratio (RR) and 95% CI for
the overall incidence of diarrhoeal disease and respiratory
tract infections were estimated by fitting Poisson regression
models to counts of diarrhoea and respiratory infections in
the treatment and placebo groups (Gardner et al. 1995).
These primary analyses were ‘intent to treat’. Separate
models were also adjusted to counts of episodes stratified by
child and household characteristics as well as season in an
effort to disaggregate the overall effect of vitamin A. The vari-
ables of special interest in this analysis were those that may be
indirect measures of pathogen prevalence and transmission
such as water source (piped water, no piped water), avail-
ability of indoor toilets (indoor toilet, no indoor toilet), pre-
sence of refrigerator (refrigerator, no refrigerator), the
number of household goods as a measure of socio-economic
status (SES; ,3, $3), the season in which the episode
occurred (winter and summer) and the child’s age and nutri-
tional status (stunted, non-stunted). The stratification by
season was carried out due to the prevalence of distinct diar-
rhoeal disease and respiratory tract infection pathogens in
Mexico during the winter (November to March) and summer
seasons (April to October) (Golubjatnikov et al. 1975;
Cravioto et al. 1990). All analyses included child’s age and
breastfeeding status (breastfed, not breastfed). Statistical sig-
nificance was set at a probability level of ,0·05 and at
,0·1 for interactions. Data were analysed using the PROC
GENMOD procedure in the Statistical Analysis System soft-
ware (SAS version 8·2; SAS Institute, Cary, NC, USA). The
study protocol was approved by the human subjects commit-
tees of the National Institute of Public Health of Mexico
and Harvard School of Public Health.
Results
In all, 200 children were recruited for the study following
the consent of their mothers. Five children were excluded
from the study due to receiving a vitamin A supplement
prior to enrollment or due to their extreme low weight-
for-age Z-scores and seven children were lost to follow-
up. The remaining 188 children were followed for up to
15 months, ninety-three children in the vitamin A group
and ninety-five children in the placebo group (Fig. 1). The
distribution of sociodemographic characteristics of study
children and households was similar between children who
received vitamin A and those who were given the placebo
(Table 1). Approximately 47–50% of households had no
access to piped water while approximately 64–70% had
no indoor toilets; 34–40% of children were stunted. The
mean duration of follow-up for children in the two treatment
groups was not significantly different (vitamin A group, 11·5
(SE 5·5) months; placebo group, 11·9 (SE 5·6) months;
P¼0·56). Approximately 1035 of the planned 1120 doses
of vitamin A or placebo were given by the project personnel
and consumed by the study children for a compliance rate
of 92%.
There were significantly fewer episodes of mild watery
diarrhoea among children in the vitamin A group compared
to children in the placebo group (RR 0·69; 95% CI 0·50,
0·93) (Table 2). There was no significant difference in the inci-
dence and duration of overall diarrhoea, severe diarrhoea or
dysentery among children receiving vitamin A and children
in the placebo group (Table 2). There were only two episodes
of persistent diarrhoea, both occurring in the placebo group.
Children in the vitamin A group had significantly fewer epi-
sodes of cough with fever compared to children in the placebo
group (RR 0·69; 95% CI 0·48, 0·98; Table 3). There were no
significant differences between the vitamin A and placebo
groups in the incidence or duration of the other types of res-
piratory infections.
Vitamin A was found to have significant effects on diar-
rhoea among some subsets of children. In this analysis diar-
rhoeal rates in the placebo group were higher among children
with better anthropometric measures, who were from house-
holds with better SES measures, and during the summer
months compared to rates among children with worse anthro-
pometric measures, from household with poorer SES
measures and during the winter season (Table 4). Vitamin
A was associated with a reduction in diarrhoea among chil-
dren during the summer season compared to the placebo
group (RR 0·74; 95% CI 0·57, 0·94). This effect was signifi-
cantly different from that found among children during the
winter months when vitamin A supplementation had no
effect on diarrhoea incidence (P value for interaction:
,0·01). Significant interactions between vitamin A and
refrigerator availability, and vitamin A and greater household
possessions were found (Table 4; P value for interaction:
0·03 and 0·02, respectively). Diarrhoea was lower among
vitamin A-supplemented children from households that had
refrigerators (RR 0·53; 95% CI 0·36, 0·77) and that had
two or more household possessions (RR 0·57; 95% CI
0·38, 0·86). There was no difference in respiratory infections
between vitamin A-supplemented children and children in the
placebo group in the stratified analysis.
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Discussion
We have found in a randomized clinical trial carried out in a
peri-urban area of Mexico City that vitamin A supplemen-
tation was associated with reductions in the rates of mild
watery diarrhoea and cough with fever but had no effect on
the overall rate of diarrhoea. A reduction in diarrhoeal disease
was found among vitamin A-supplemented children from
households with better SES measures and during the
summer months. No differences in the effect of vitamin A
on respiratory infections were found in the stratified groups.
The present findings suggest that vitamin A supplementation
does not have an overall effect on all morbidity outcomes
but does have an effect on specific outcomes and among chil-
dren stratified by personal and household characteristics and
by season.
Previously published studies have shown that the effect of
vitamin A on diarrhoeal disease and respiratory tract infec-
tions in stratified analyses can be quite different from effects
found at an aggregate level. Trials which have reported no
overall effect on diarrhoea have simultaneously reported
both reductions and increases in diarrhoea among children
stratified by age, nutritional status and feeding mode
(Ramakrishnan et al. 1995; Dibley et al. 1996; Fawzi et al.
2000). Similarly, trials which have reported no consistent
effect or even a negative effect of vitamin A on respiratory
tract infections have reported quite different effects between
children who were stratified by nutritional status, age and
HIV status (Dibley et al. 1996; Sempertegui et al. 1999;
Fawzi et al. 2000). These reported differences suggest that
vitamin A supplementation may be producing effects
through mechanisms that are not clearly understood at
present.
Such complexity may be partly due to the impact vitamin A
has on the host’s immune response against specific pathogens.
Vitamin A supplementation up-regulates the T helper type 2
(Th2) lymphocyte response which is protective against such
pathogens as Ascaris lumbricoides (Cooper et al. 2000) and
down-regulates the T helper type 1 (Th1) lymphocyte
response protective against intracellular infections such as Sal-
monella spp. (Mizuno et al. 2003). Vitamin A deficiency, in
contrast, down-regulates the Th2 response and up-regulates
the Th1 response (Wiedermann et al. 1993; Cantorna et al.
1994, 1995; Long et al. 2006a). These regulatory effects of
vitamin A on the immune response suggests that effectiveness
of supplementation in modifying pathogen-specific clinical
outcomes may depend on the role of the Th1–Th2 responses
in these outcomes.
Assessed for
eligibility (n=200)
Randomized (n=195)
Allocation to vitamin A
group (n=97)
Received allocated
intervention (n=97)
Allocation to placebo
group (n=98)
Received allocated
intervention (n=98)
Lost to follow-up
(n=4)
Lost to follow-up
(n=3)
Analysed (n=95)Analysed (n=93)
Not meeting
inclusion
criteria
Excluded (n=5)
Fig. 1. Trial profile.
Table 1. Baseline characterisitics of study children and households
Percentage with
characteristics
Characteristics
Vitamin A
(n 93)
Placebo
(n 95) P value*
Child age
6–12 months 82·4 81·3
12–18 months 18·1 17·5 0·64
Boys 49·2 50·2 0·43
Mother’s education
Less than 6 years 43·4 35·1
Completed elementary 35·5 41·9
Completed secondary 11·8 12·1
Greater than secondary 9·2 10·8 0·76
Water source
Indoor tap 15·5 15·1
Outdoor tap 34·6 37·3
No access to piped water 49·8 47·5 0·85
Bathroom
Inside house 28·7 34·5
Outside house 69·8 63·8
No bathroom 1·3 2·4 0·63
Number of household appliances
None 6·9 7·3
1–2 67·1 67·0
3–4 24·6 20·7
5–6 1·4 4·9 0·63
Refrigerator in house
No 72·6 69·1
Yes 27·4 30·9 0·64
Height-for-age Z-score
, 2 2 40·0 33·8
2 2 to 21 32·7 40·0
. 2 1 27·2 26·1 0·69
Weight-for-height Z-score
, 2 2 10·9 6·0
2 2 to 21 25·4 28·3
. 2 1 63·6 65·6 0·14
*P values for overall group differences calculated using x2 tests.
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Table 2. Incidence rate of diarrhoea among study children administered vitamin A or placebo
Vitamin A group Placebo group
No. of episodes Child-years at risk Incidence rate No. of episodes Child-years at risk Incidence rate RR* 95% CI
Diarrhoea (all types) 214 58·7 3·64 250 63·1 3·96 0·79 0·60, 1·02
Mild watery diarrhoea 154 58·2 2·64 161 62·4 2·58 0·68 0·50, 0·93
Severe watery diarrhoea 53 57·6 0·91 76 61·9 1·22 0·90 0·51, 1·59
Dysentery 9 58·8 0·15 19 62·3 0·30 0·60 0·14, 2·50
* Incidence relative rates (RR) calculated using Poisson regression models; child’s age, breastfeeding status, season, nutritional status and household socio-economic status characteristics were included in the models.
Table 3. Incidence rate of respiratory symptoms among study children administered vitamin A or placebo
Vitamin A group Placebo group
No. of episodes Child-years at risk Incidence rate No. of episodes Child-years at risk Incidence rate RR* 95% CI
Cough 179 56·5 3·16 206 60·1 3·42 0·73 0·68, 1·09
Cough with difficulty breathing 24 53·1 0·45 17 56·5 0·30 1·03 0·49, 2·17
Cough with fever 84 54·3 1·54 113 58·5 1·93 0·69 0·48, 0·98
* Incidence relative rates (RR) calculated using Poisson regression models; child’s age and breastfeeding status were included in the model.
Table 4. Impact of vitamin A on the incidence of diarrhoea among children stratified by personal and household characteristics
Vitamin A Placebo
Modifier Level Episodes Child-years Incidence rate Episodes Child-years Incidence rate RR* 95% CI P value P for interaction
Season Winter 61 20·7 2·94 55 23·7 2·31 1·31 0·91, 1·90 0·14 ,0·01
Summer 153 37·9 4·03 195 39·3 4·95 0·74 0·57, 0·94 0·01
No. of possessions #2 152 39·5 3·84 167 42·9 3·89 0·91 0·71, 1·17 0·47 0·01
.2 30 12·5 2·39 68 15·4 4·40 0·57 0·38, 0·86 ,0·01
Refrigerator No 147 37·3 3·93 138 37·6 3·66 0·8 0·68, 1·13 0·33 0·03
Yes 35 14·7 2·38 93 20·0 4·65 0·53 0·36, 0·77 ,0·01
Height-for-age , 2 2 64 14·8 4·32 44 15·0 2·92 1·08 0·68, 1·73 0·72 0·08
Z-score $ 2 2 80 24·7 3·22 147 33·1 4·42 0·69 0·52, 0·93 0·01
* Incidence relative rates (RR) calculated using Poisson regression models; child’s age and breastfeeding status were included in the model.
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The regulation of the immune response by vitamin A may
underlie the effect supplementation has on diarrhoeal disease
and respiratory tract infections in different community settings.
The lack of a clear, overall effect of supplementation on diar-
rhoeal disease may be due to the treatment of diarrhoeal disease
as aetiologically a single disease. There is, in fact, a very exten-
sive group of pathogens that can cause diarrhoeal disease, each
of which can have quite distinct transmission routes and means
of inducing pathogenesis (Farmer & Kelly, 1991; DuPont &
Mathewson, 1998; Long et al. 1999). The grouping together of
all diarrhoeas regardless of cause may be obscuring pathogen-
specific effects of vitamin A supplementation and so may be
biasing results towards the null (Long et al. 2006c). In contrast,
the significant reduction ofmildwatery diarrhoeamay reflect the
effect of vitamin A supplementation on a more restricted range
of pathogens. We have found that vitamin A supplementation is
associated with reductions in watery diarrhoea associated with
norovirus infections (Long et al. 2006b). Similarly, the clear
effect of supplementation on the overall incidence of cough
with fever may reflect the impact of supplementation on the
immune response to a much smaller number of pathogens that
cause respiratory tract infections (Wilhelmi & A, 2003).
The effects of supplementation on diarrhoea seen in chil-
dren stratified by season and household characteristics could
reflect the immuno-regulatory effects of vitamin A between
children exposed to distinct groups of pathogens. There is a
strong seasonal prevalence of different types of diarrhoeal dis-
ease pathogens in Mexico City, with rotavirus being the most
prevalent diarrhoeal pathogen in the winter months, and diar-
rhoeal Escherichia coli and norovirus being more prevalent in
the summer months (Calva et al. 1988; Velazquez et al. 1996;
Long et al. 2006b). The up-regulation of a Th2 response by
vitamin A may have contributed to the decrease in diarrhoea
in the summer. This response is protective against such patho-
gens as enterotoxigenic E. coli and norovirus which are more
prevalent during this period (Long et al. 1994, 2006b). In con-
trast, a developed Th1 response may be more protective
against rotavirus (VanCott et al. 2000). The down-regulation
of this response among vitamin A-supplemented children
could have led to a non-significant, greater prevalence of rota-
virus among these children in the winter season.
The impact of supplementation on children when stratified
by household characteristics may again reflect the children’s
exposure to different types of diarrhoeal pathogens. In this
case the number of household possessions and the presence
or absence of refrigerator may serve as markers for the
transmission of such pathogens (Bandres et al. 1988;
Levine et al. 1993). However, the consistently beneficial
effect of supplementation on diarrhoea among children
from households with better SES measures is paradoxical.
Norovirus, an enteral virus increasingly recognized as an
important cause of paediatric diarrhoea in developing
countries, was the most prevalent pathogen isolated in the
summer (Long et al. 2006b). The incidence of this pathogen
and the reductions associated with supplementation were
greatest among children from households that had refriger-
ators and that had better SES measures. The paradoxical
effect of supplementation in the stratified analysis may
reflect the relative importance of diarrhoeas due to this
pathogen compared to other enteropathogens (Long et al.
2006c).
The lack of differential effects of supplementation on cough
with fever in the stratified analysis may reflect the epidemiol-
ogy of respiratory tract infections. The transmission of
respiratory tract pathogens does not involve any environmen-
tal component since transmission is largely through direct
person-to-person contact (Berman, 1991). As a result, the
exposure of children to these pathogens could be more
evenly distributed through a community regardless of house-
hold differences in SES characteristics such as sanitation or
water availability.
One limitation of the present study is that we have no indi-
cators of the children’s pre-randomization vitamin A status.
Differences in the initial status of study children could poss-
ibly determine the effectiveness of supplementation with
deficient children benefiting more and non-deficient children
benefiting less. No blood samples were taken from children
in the present study, so it was not possible to address their
vitamin A status. A probabilistic national survey carried out
in Mexico has shown that overt vitamin A deficiency
(,100mg/l) and sub-clinical deficiency (100–200mg/l)
among children living in Mexico City is minimal (Villalpando
et al. 2003). A second limitation is that we have not presented
any pathogen-specific effects associated with vitamin A
supplementation.
We have suggested that the distinct effects of vitamin A
supplementation on specific outcomes may reflect its impact
on the host’s pathogen-specific immune response. The present
findings suggest there is a greater heterogeneity of effects in
the children’s response to supplementation for diarrhoeal dis-
ease episodes than for respiratory tract infections. If further
work shows that vitamin A is protective against a specific
group of pathogen infections then it would be imperative to
design vitamin A supplementation programmes that target
groups of children that would benefit most. The timing of sup-
plementation based on the seasonal prevalence of such patho-
gens is one obvious strategy which could potentially enhance
the effectiveness of supplementation programmes.
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